ALA shows it can scale: Pathway towards an “off the shelf” cancer treatment
Next Investors
Apr 17, 2023
This morning Arovella Therapeutics (ASX: ALA) released new data indicating its treatment, ALA-101, has the potential to be a novel, ‘off the shelf’ cell therapy to treat leukemias and lymphomas.